<?xml version="1.0" encoding="UTF-8"?>
<clinical_study rank="43496">
  <!-- This xml conforms to an XML Schema at:
    http://clinicaltrials.gov/ct2/html/images/info/public.xsd
 and an XML DTD at:
    http://clinicaltrials.gov/ct2/html/images/info/public.dtd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on June 04, 2014</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>http://clinicaltrials.gov/show/NCT01846325</url>
  </required_header>
  <id_info>
    <org_study_id>046401</org_study_id>
    <nct_id>NCT01846325</nct_id>
  </id_info>
  <brief_title>The Effects of Administration of Combined Docosahexaenoic Acid and Vitamin E Supplements on Spermatogram and Seminal Plasma Oxidative Stress in Infertile Men With Asthenozoospermia</brief_title>
  <sponsors>
    <lead_sponsor>
      <agency>National Nutrition and Food Technology Institute</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>National Nutrition and Food Technology Institute</source>
  <oversight_info>
    <authority>Iran: Ministry of Health</authority>
  </oversight_info>
  <brief_summary>
    <textblock>
      Since docosahexaenoic acid (DHA) level in sperm membrane has been shown to be decreased in
      asthenozoospermic men, the investigators hypothesized that DHA supplementation may improve
      it. Furthermore, the investigators added vitamin E to it to protect its unsaturated bonds
      which are susceptible to oxidation and production of free oxygen radicals.
    </textblock>
  </brief_summary>
  <overall_status>Completed</overall_status>
  <start_date>April 2011</start_date>
  <primary_completion_date type="Actual">December 2012</primary_completion_date>
  <phase>Phase 2/Phase 3</phase>
  <study_type>Interventional</study_type>
  <study_design>Allocation: Randomized, Endpoint Classification: Efficacy Study, Intervention Model: Parallel Assignment, Masking: Double Blind (Subject, Caregiver, Investigator, Outcomes Assessor), Primary Purpose: Treatment</study_design>
  <primary_outcome>
    <measure>sperm motility</measure>
    <time_frame>12 weeks</time_frame>
    <safety_issue>No</safety_issue>
    <description>spermatogram</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>sperm count</measure>
    <time_frame>12 weeks</time_frame>
    <safety_issue>No</safety_issue>
    <description>spermatogram</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>seminal oxidative stress</measure>
    <time_frame>12 weeks</time_frame>
    <safety_issue>No</safety_issue>
    <description>ELISA</description>
  </secondary_outcome>
  <number_of_arms>4</number_of_arms>
  <enrollment type="Actual">180</enrollment>
  <condition>Asthenozoospermia</condition>
  <arm_group>
    <arm_group_label>DHA plus vitamin E</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Cap DHA 460mg plus vitamin E 600mg per day</description>
  </arm_group>
  <arm_group>
    <arm_group_label>VitaminE plus placebo</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>vitamin E 600 mg plus placebo</description>
  </arm_group>
  <arm_group>
    <arm_group_label>placebo plus placebo</arm_group_label>
    <arm_group_type>Placebo Comparator</arm_group_type>
    <description>DHA shaped placebo plus vitamin E shaped placebo</description>
  </arm_group>
  <arm_group>
    <arm_group_label>DHA plus placebo</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>460 mg DHA plus placebo</description>
  </arm_group>
  <intervention>
    <intervention_type>Dietary Supplement</intervention_type>
    <intervention_name>vitamin E</intervention_name>
    <arm_group_label>DHA plus vitamin E</arm_group_label>
    <arm_group_label>VitaminE plus placebo</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Dietary Supplement</intervention_type>
    <intervention_name>DHA</intervention_name>
    <arm_group_label>DHA plus vitamin E</arm_group_label>
    <arm_group_label>DHA plus placebo</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>placebo</intervention_name>
    <arm_group_label>VitaminE plus placebo</arm_group_label>
    <arm_group_label>placebo plus placebo</arm_group_label>
    <arm_group_label>DHA plus placebo</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion criteria:

          -  Willing to participate in the study and filling out the informed consent form

          -  should be infertile (no conception after 12 months intercourse without any
             contraception)

          -  age 20-45 y.o, idiopathic asthenospermia according to WHO criteria

          -  normal hormonal profile

        Exclusion criteria:

          -  any infection in genitourinary (GU) tract

          -  any anatomical abnormality in GU tract

          -  any chronic disease during last 3 months

          -  any surgery in GU tract

          -  consumption of omega-3 fatty acids and/or vitamin E supplements during last 3 months
      </textblock>
    </criteria>
    <gender>Male</gender>
    <minimum_age>20 Years</minimum_age>
    <maximum_age>45 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <verification_date>December 2013</verification_date>
  <lastchanged_date>December 29, 2013</lastchanged_date>
  <firstreceived_date>May 1, 2013</firstreceived_date>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>National Nutrition and Food Technology Institute</investigator_affiliation>
    <investigator_full_name>Dr Azita Hekmatdoost</investigator_full_name>
    <investigator_title>Dr</investigator_title>
  </responsible_party>
  <is_fda_regulated>No</is_fda_regulated>
  <has_expanded_access>No</has_expanded_access>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm  -->
    <mesh_term>Asthenozoospermia</mesh_term>
  </condition_browse>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm  -->
    <mesh_term>Vitamin E</mesh_term>
    <mesh_term>Alpha-Tocopherol</mesh_term>
    <mesh_term>Tocopherols</mesh_term>
    <mesh_term>Tocotrienols</mesh_term>
    <mesh_term>Vitamins</mesh_term>
  </intervention_browse>
  <!-- Results have not yet been posted for this study                                -->
</clinical_study>
